TABLE 2.
Species | Antifungal agent | No. of isolates tested | MIC (μg/ml) |
ECVb |
||
---|---|---|---|---|---|---|
Range | Modea | ≥95% | ≥97.5% | |||
S. schenckii | Amphotericin B | 263 | 0.03 to 32 | 1 | 4 | 4 |
Itraconazole | 194 | 0.06 to ≥32 | 0.5 | 2 | 2 | |
Ketoconazole | NDc | |||||
Posaconazole | 301 | 0.06 to 16 | 1 | 2 | 4 | |
Voriconazole | 252 | 0.5 to >32 | 16 | 64 | 64 | |
Terbinafine | ND | |||||
S. brasiliensis | Amphotericin B | 486 | 0.03 to 8 | 1 | 4 | 4 |
Itraconazole | 306 | 0.01 to 32 | 1 | 2 | 2 | |
Ketoconazole | 338 | 0.01 to 2 | 0.5 | 2 | 2 | |
Posaconazole | 200 | 0.01 to 4 | 1 | 2 | 2 | |
Voriconazole | 200 | 0.5 to 32 | 8 | 32 | 32 | |
Terbinafine | 368 | ≤0.01 to 1 | 0.06 | 0.12 | 0.25 |
Mode, most frequent MIC.
Calculated CLSI ECVs comprising ≥95% and ≥97.5% of the statistically modeled population; the values are based on MICs determined by the CLSI M38-A2 broth dilution method (21).
ND, not determined, due to an insufficient number of isolates or laboratories for ECV calculation.